Quit Meth Research Study
Researchers at the Medical University of South Carolina and Behavioral Health Services of Pickens County are conducting a study on an investigational treatment to help people quit or reduce their use of methamphetamines.
Fast Facts
Interested in Stopping or Reducing Meth Use
18-65 Years Old
Compensation Provided
Conducted in Pickens, SC
Study Background
This study is for those 18-65 who have a desire to quit or reduce methamphetamine.
Do you use meth or know someone who does? If you are 18 to 65 and not currently enrolled in treatment, you may qualify for a research study evaluating investigational medication to help decrease methamphetamine use. Information is completely confidential and participation is compensated.
If you are eligible and choose to enroll, you will be part of the study for up to 19 weeks, during which you’ll go through screening, treatment with the investigational medication, and follow-up. Eventually, the findings of this study might be useful for helping people quit meth and improve their quality of life.
Study Background
This study is for those 18-65 who have a desire to quit or reduce methamphetamine.
Do you use meth or know someone who does? If you are 18 to 65 and not currently enrolled in treatment, you may qualify for a research study evaluating investigational medication to help decrease methamphetamine use. Information is completely confidential and participation is compensated.
If you are eligible and choose to enroll, you will be part of the study for up to 19 weeks, during which you’ll go through screening, treatment with the investigational medication, and follow-up. Eventually, the findings of this study might be useful for helping people quit meth and improve their quality of life.
Additional Information
In this research study, we want to evaluate the effectiveness of a medication called extended release naltrexone plus bupropion XL in helping people reduce methamphetamine use.
You may qualify for a study if you meet the following criteria.
Inclusion Criteria:
- 18-65 years old
- Use meth regularly
- Interested in stopping or reducing meth use
Exclusion Criteria:
- Suicidal or homicidal ideation
- History of epilepsy, seizure disorder, or head trauma with neurological sequelae (such as loss of consciousness that required hospitalization)
- Current anorexia nervosa or bulimia
- Have been in a pharmacological or behavioral treatment for meth use disorder in the past 6 months
- Have taken an investigational drug in another study in the past 30 days
- Have prescribed and taken naltrexone or bupropion in the past 30 days
- Enrolled in formal behavioral or pharmacological Substance Use Disorder (SUD) treatment services
The entire study lasts up to 19 weeks. Once enrolled, the study involves:
- Screening phase (up to 3 visits, 21 days max)
- Treatment phase (12 weeks)
- Follow-up (4 weeks)
You will be provided with either the study medication (extended release naltrexone plus bupropion XL) or a placebo, which looks like the study medication but has no active ingredients. These will be a combination of injectable and oral medications.
As a participant, you can receive up to $1610 for your time and effort.
There is no cost for you to participate in our research study.
